FindTrial
Sign In

A Prospective Observational Study on the Efficacy and Safety of Dutasteride 0.5 mg/Tadalafil 5 mg Fixed-Dose Combination for Patients with Persistent BPH Symptoms

A Prospective Observational Study on the Efficacy and Safety of Dutasteride 0.5 mg/Tadalafil 5 mg Fixed-Dose Combination for Patients with Persistent BPH Symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0012316
Enrollment
50
Registered
2026-07-22
Start date
2026-08-12
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chung-Ang Univerisity Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (Benign Prostatic Hyperplasia, BPH)

Exclusion criteria

Exclusion criteria: 1. Patients who have characteristics that make it difficult to comply with the study protocol requirements 2. Patients with diseases or medical conditions that are not suitable for this study 3. Patients who are unable to provide or refuse to provide informed consent

Design outcomes

Primary

MeasureTime frame
Maximum flow rate (Q_max), Post-void residual volume (PVR), Prostate volume (PV), Serum prostate-specific antigen (PSA)—

Secondary

MeasureTime frame
(IPSS) (QoL) (IIEF)—

Countries

Korea, Republic of

Contacts

Public ContactSe Young Choi

Chung-Ang University

alse3025@hanmail.net+82-2-6299-1810

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Aug 10, 2026